Predictors of Remission and Renal Outcomes in Lupus Nephritis in Assuit University Hospitals.
Launched by ASSIUT UNIVERSITY · Jan 19, 2024
Trial Information
Current as of November 14, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Predictors of Remission and Renal Outcomes in Lupus Nephritis in Assuit University Hospitals," is focused on understanding how to improve kidney health in patients with lupus nephritis, a condition that affects the kidneys in people who have systemic lupus erythematosus (SLE). The main goal is to find out what factors—like certain medical histories, lab results, and kidney tissue samples—are linked to better or worse kidney health in these patients.
To be eligible for the study, participants must be over 18 years old and have a confirmed diagnosis of lupus nephritis through a kidney biopsy. If you have serious conditions like uncontrolled high blood pressure, diabetes, or severe heart diseases, or if you have mental health issues, you would not be able to participate. If you join the study, you can expect to undergo a thorough medical history review, a physical exam, and some tests to assess your disease activity, along with a kidney biopsy. This research could help doctors understand more about how to manage kidney health in lupus patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \> 18 years and SLE patients with biopsy-proven LN.
- Exclusion Criteria:
- • Severe physical disability, patients with uncontrolled hypertension, diabetes mellitus, or severe ischemic heart diseases, patients with mental illness, patients with overlap syndrome, and refusal to participate in the study.
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported